Literature DB >> 12512958

Expression of the p75 TNF receptor is linked to TNF-induced NFkappaB translocation and oxyradical neutralization in glial cells.

Joel M Dopp1, Theodore A Sarafian, Francesca M Spinella, Michelle A Kahn, Hungyi Shau, Jean de Vellis.   

Abstract

Tumor necrosis factor (TNF)-family cytokines induce reactive oxygen species (ROS) that injure vulnerable populations of brain cells. Among glia, oligodendrocytes are particularly susceptible to TNF-induced ROS whereas microglia are protected. We previously found that oligodendrocytes in vitro predominantly express the p55 type-1 TNF receptor, while microglial cells express both type-1 and p75 type-2 receptors. We hypothesized that differential TNF receptor expression and attendant signaling underlies the relative vulnerability of oligodendrocytes, versus microglia, to TNF-induced injury. To test this hypothesis, purified cultures of glial cells were incubated 0-48 hr with TNFalpha or lymphotoxin-alpha, following which levels of ROS, glutathione (GSH), nuclear factor kappa-B (NFkappaB) translocation, and anti-oxidant proteins and activity were measured. 48 hr exposure to TNF increased ROS levels 28% and decreased GSH levels 17% in oligodendrocytes, but decreased levels ROS levels 24% and increased GSH levels 112% increase in microglia. Thirty to 180 min exposure to TNF increased NFkappaB nuclear translocation to a greater extent and for a longer time in microglia versus oligodendrocytes, and this was followed 24-48 hr later with 3- to 13-fold increases in microglia manganese superoxide dismutase protein levels and 6-fold increases in enzyme activity. Collectively, these data suggest that signals transduced through the p75 receptor activate anti-oxidant mechanisms that protect microglia from TNF-induced injury. Lacking such signals, oligodendrocytes are considerably more vulnerable to the injurious effects of TNF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12512958     DOI: 10.1023/a:1021608724117

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  46 in total

1.  NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.

Authors:  S Kreuz; D Siegmund; P Scheurich; H Wajant
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  Expression of the antioxidant gene NKEF in the central nervous system.

Authors:  T A Sarafian; C Huang; A Kim; J de Vellis; H Shau
Journal:  Mol Chem Neuropathol       Date:  1998-05

Review 3.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

4.  Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2.

Authors:  P Zhang; B Liu; S W Kang; M S Seo; S G Rhee; L M Obeid
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

5.  Distribution of mitochondrial manganese superoxide dismutase among rat glial cells in culture.

Authors:  E Pinteaux; M Perraut; G Tholey
Journal:  Glia       Date:  1998-04       Impact factor: 7.452

6.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

7.  bcl-2 expression decreases methyl mercury-induced free-radical generation and cell killing in a neural cell line.

Authors:  T A Sarafian; L Vartavarian; D J Kane; D E Bredesen; M A Verity
Journal:  Toxicol Lett       Date:  1994-11       Impact factor: 4.372

8.  Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats.

Authors:  Y Kuroda; Y Shimamoto
Journal:  J Neuroimmunol       Date:  1991-11       Impact factor: 3.478

9.  Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity.

Authors:  V Goossens; J Grooten; K De Vos; W Fiers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

10.  A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor.

Authors:  M Rothe; S C Wong; W J Henzel; D V Goeddel
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

View more
  17 in total

1.  Blockade of tumour necrosis factor-α in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology.

Authors:  H Batoulis; M S Recks; F O Holland; F Thomalla; R O Williams; S Kuerten
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

Review 2.  TNF receptor 2 pathway: drug target for autoimmune diseases.

Authors:  Denise Faustman; Miriam Davis
Journal:  Nat Rev Drug Discov       Date:  2010-05-21       Impact factor: 84.694

Review 3.  Chronicles of a death foretold: dual sequential cell death checkpoints in TNF signaling.

Authors:  Marie Anne O'Donnell; Adrian T Ting
Journal:  Cell Cycle       Date:  2010-03-15       Impact factor: 4.534

4.  Interleukin-6 and type 1 interferons inhibit varicella zoster virus replication in human neurons.

Authors:  Christina N Como; Catherine M Pearce; Randall J Cohrs; Nicholas L Baird
Journal:  Virology       Date:  2018-07-04       Impact factor: 3.616

5.  Tumor necrosis factor-alpha mediates photoreceptor death in a rodent model of retinal detachment.

Authors:  Toru Nakazawa; Maki Kayama; Morin Ryu; Hiroshi Kunikata; Ryou Watanabe; Masayuki Yasuda; Jiro Kinugawa; Demetrios Vavvas; Joan W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

6.  TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.

Authors:  Deepika Sharma; Ankit Malik; Clifford Guy; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

7.  Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2008-09-26       Impact factor: 4.030

8.  Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity.

Authors:  Patrick J Shaw; Kevin M Beggs; Erica M Sparkenbaugh; Christine M Dugan; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2009-07-28       Impact factor: 4.849

Review 9.  Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.

Authors:  Hymie Anisman
Journal:  J Psychiatry Neurosci       Date:  2009-01       Impact factor: 6.186

Review 10.  Redox control of microglial function: molecular mechanisms and functional significance.

Authors:  Ana I Rojo; Gethin McBean; Marina Cindric; Javier Egea; Manuela G López; Patricia Rada; Neven Zarkovic; Antonio Cuadrado
Journal:  Antioxid Redox Signal       Date:  2014-05-05       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.